2013
DOI: 10.1007/s13273-013-0047-7
|View full text |Cite
|
Sign up to set email alerts
|

Effect of bisphenol A exposure during early development on glucose metabolism and adipokine expression in adolescent female rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 28 publications
0
8
0
Order By: Relevance
“…Of these, there were nine studies on mice, of which there were one, four and four studies, respectively, in Tier 1 (van Esterik et al, 2014 [RefID 7393]), Tier 2 (Malaisé et al, 2017 [RefID 4815]; Junge et al, 2018 [RefID 12262]; Susiarjo et al, 2015 [RefID 7022] and Wang et al, 2014b [RefID 7759]) and Tier 3 (Rubin et al., 2017 [RefID 6319]; Ziv‐Gal et al, 2015 [RefID 9143]; Dobrzyńska et al, 2015 [RefID 1644] and Patel et al, 2013 [RefID 5697]). There were 12 studies on rats, of which eight, four and zero studies in Tier 1 (Hass et al, 2016 [RefID 2610]; Jiang et al, 2014 [RefID 3190]; Song et al, 2014b [RefID 6829]; Desai et al ( 2018a ) [RefID 11817]; Dunder et al, 2018 [RefID 11866]; Xia et al, 2014 [RefID 8103]; Quan et al, 2017 [RefID 6025] and Uchtmann et al, 2020 [RefID 13784]), Tier 2 (Ma et al., 2013 [RefID 4748]; Mao et al, 2017 [RefID 4865]; Zhang et al, 2013 [RefID 8798] and Anteur et al, 2016 [RefID 13773]) and Tier 3, respectively. The doses that were found to increase the body weight were in the range 0.45–10,000 μg/kg bw per day.…”
Section: Assessmentmentioning
confidence: 99%
See 3 more Smart Citations
“…Of these, there were nine studies on mice, of which there were one, four and four studies, respectively, in Tier 1 (van Esterik et al, 2014 [RefID 7393]), Tier 2 (Malaisé et al, 2017 [RefID 4815]; Junge et al, 2018 [RefID 12262]; Susiarjo et al, 2015 [RefID 7022] and Wang et al, 2014b [RefID 7759]) and Tier 3 (Rubin et al., 2017 [RefID 6319]; Ziv‐Gal et al, 2015 [RefID 9143]; Dobrzyńska et al, 2015 [RefID 1644] and Patel et al, 2013 [RefID 5697]). There were 12 studies on rats, of which eight, four and zero studies in Tier 1 (Hass et al, 2016 [RefID 2610]; Jiang et al, 2014 [RefID 3190]; Song et al, 2014b [RefID 6829]; Desai et al ( 2018a ) [RefID 11817]; Dunder et al, 2018 [RefID 11866]; Xia et al, 2014 [RefID 8103]; Quan et al, 2017 [RefID 6025] and Uchtmann et al, 2020 [RefID 13784]), Tier 2 (Ma et al., 2013 [RefID 4748]; Mao et al, 2017 [RefID 4865]; Zhang et al, 2013 [RefID 8798] and Anteur et al, 2016 [RefID 13773]) and Tier 3, respectively. The doses that were found to increase the body weight were in the range 0.45–10,000 μg/kg bw per day.…”
Section: Assessmentmentioning
confidence: 99%
“…In male offspring, the glucose level was increased at 3 weeks, but not at 9 weeks, whereas in female offspring, no effects were observed at 3 weeks or 9 weeks. In the Tier 2 study Zhang et al ( 2013 ) [RefID 8798], only female rats were exposed on GD6–PND21 to 33 or 310 μg/dam during gestation, 80 or 758 μg/kg bw per day at the end of gestation. In F1 females, the glucose level was increased with 80 μg, but not with 758 μg at 7 weeks of age.…”
Section: Assessmentmentioning
confidence: 99%
See 2 more Smart Citations
“…Insulin resistance and common property such as hypertension, hyperlipidemia, and abdominal obesity are common phenomenon in T2DM and obesity [ 8 ]. The prevalence rate of people who have both T2DM and obesity has rapidly increased all over the world every year, and the rates of increase show no signs of slowing [ 1 , 2 , 9 ]. Even though T2DM and obesity are a risk factor for cardiovascular disease, most of the treatment of metabolic syndrome only focuses on the reduction of blood glucose levels or the regulation of body weight.…”
Section: Introductionmentioning
confidence: 99%